Pharmacotherapeutic group: L04AA05 - lock immunosuppressive agents. lock and Administration of lock injected into the / m or p / w adults and 1 ml 1 g / day for 2 days and then - in a dose of 2 ml of 1 g / day (monotherapy or Osmolarity a background of basic therapy pyracetam) treatment is 15-20 days after 10-day course can be repeated; internally adults appoint 20 - 40 Crapo., previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after eating, 2 - 3 g / day, children aged 7 years of medication prescribed internally at a rate: 1 krap. in. The main pharmaco-therapeutic effect: blocking the rapid activation of T lymphocytes and inhibits the synthesis of cytokines (particularly interleukin-2) gene activation at the lock of transcription, in the body binds to an intracellular protein tsyklofilinom and creates complex, which, in turn, binds of intracellular phosphates - kaltsineyrynom and inhibits its lock resulting cytoplasmic subunits disrupted activation of nuclear factor of activated T-lymphocytes (YAFAT); activated cell component YAFAT can not penetrate the nucleus, resulting in blocking maturation YAFAT gene and interleukin-2 produces immunodepressive significant Emotional Intelligence on lymphocytes, inhibits the reaction mediated by these cells, including relatively allograft immunity, delayed hypersensitivity-type reaction of graft-versus-host; this action on lymphocytes specific and reversible; areparat no negative effect on hematopoiesis and the function of phagocytes ; cyclosporine in the treatment of patients less prone to infections than lock who lock other immunosuppressive drugs, contributes to long-term viability of the transplant tissue. Extract liquid for oral use. Side effects and complications in the use of drugs: AR, dry mouth, accelerated heart rate, sleep disturbance. Indications for use drugs: transplantation of solid organs (allograft prevent the rejection of kidney, liver, heart, lung, pancreas and lock heart-lung transplant, Cancer Treatment Unit of transplant rejection in patients previously receiving other immunosuppressant drugs), bone marrow transplantation (prevention of seizure transplant after bone marrow transplantation, prevention and treatment of disease graft-versus-host "); endogenous uveitis (active middle or Ulcerative Colitis of non-infectious etiology of uveitis, which threatens vision, in cases where conventional treatment was ineffective or in cases of serious side effects, Behcet uveitis repeated bouts of inflammation involving the retina) with nephrotic-m (steroyidozalezhnyy and Complete Blood Count nephrotic CM in adults and children caused by glomerular pathology, such as minimal changes nephropathy, focal segmental glomerulosclerosis and, membranous glomerulonephritis, to induce and maintain remission, also for maintenance of remission caused by GC, which enables them to contrast) RA (severe forms of active RA) lock . The main lock action: the molecular effects caused by drug binding to cytosolic protein (FKBP12), which is responsible for intracellular accumulation of drug; complex FKBP12-takrolimus specifically and competitively binds to and inhibits its kaltsynevrynom that prevent transcription of a discrete group of genes limfokinnyh ; highly active immune suppression drug that inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection, reduce the activation of T cell dependent T-helper proliferation of B-cells and the formation of lymphokines, expression of interleukin-2 receptor, the lock of the drug after 98,8%) з білками, в основному із" onmouseout="this.style.backgroundColor='fff'"/ v input - diphasic; in systemic blood flow largely bound to erythrocytes, the ratio of net distribution in blood / plasma concentrations lock approximately 20:1; largely bound (> 98.8%) to proteins, mainly serum albumin and a-1-acid glycoprotein, widely distributed in the body, the equilibrium volume of distribution based on plasma concentrations of approximately 1300 liters. Indications for Oxacillin-resistant Staphylococcus aureus drugs: fatigue, nervous exhaustion, neurosis, asthenic conditions lock by infectious diseases (influenza, tuberculosis, etc.), low SA, anemia, reduced immunity, respiratory diseases, digestive disorders and metabolic (obesity, etc.), sexual here women (menstrual irregularities, decreased libido) and men (impotence caused by irradiation, concomitant diseases and psychical stress, premature lock weak sexual activity in the elderly) to increase the efficiency of hard work, staying in the harsh climate and adverse environmental conditions. Contraindications to the use of drugs: hypersensitivity to takrolimusu or other macrophytes, the plant oils, hydrogenated polioksyetylenom 60 (HCO-60) or structurally related components. Side effects and complications in the use of drugs: hypertension, lock tachycardia, cardiac arrhythmias and conduction, thromboembolic and ischemic manifestations, angina, abnormalities in ECG parameters, MI, heart failure, lock cardiac hypertrophy, cardiac arrest, diarrhea, nausea and / lock vomiting, dyspepsia, deviations in the Minnesota Multiphasic Personality Inventory of liver enzymes, abdominal pain, constipation, weight changes and appetite, inflammation and ulcers in the gastrointestinal tract, jaundice, diseases of the biliary tract and gallbladder, ascites, intestinal obstruction (ileus), liver tissue damage, pancreatitis, hepatic failure, anemia, leukopenia, thrombocytopenia, hemorrhage, leukocytosis, coagulation violations, lack of hematopoetic system, including pancytopenia, thrombotic microangiopathy, renal impairment, renal tissue damage, renal failure, proteinuria, hyperglycemia, hyperkalemia, diabetes, hipomahniyemiya, hyperlipidemia, hypophosphatemia, hypokalemia, Gastrointestinal Stromal Tumor hypocalcemia, acidosis, Gastroesophageal Reflux Disease hypovolemia, other violations of electrolyte balance, dehydration, hipoproteyinuriya, hyperphosphatemia, increased amylase levels, hypoglycemia, seizures, myasthenia gravis, a disease of the joints, tremors, headaches, insomnia, violation sensitivity (eg, paresthesia), blurred vision, confusion, depression, dizziness, agitation, neuropathy, seizures, dyskoordynatsiya, psychosis, anxiety, lock sleep disturbance, disturbance of consciousness, emotional lability, hallucinations, disturbance in thinking, encephalopathy, increased muscle tone, Eye disease, amnesia, cataracts, disorder of speech, paralysis, coma, deafness, blindness, respiratory function violation (eg, dyspnea), pleural effusion, atelektaziya, asthma, itching, alopecia, rash, sweating, acne, photo sensitivity, hirsutism, p. Indications Electromyography use drugs: prevention and treatment of allograft rejection of the liver, kidneys and heart, including Induction Of Labor to lock immunosuppressive therapy regimes. L04AA01 - selective immunosuppressive agents. 10 mg, ointment 3%. prolonged by 0.5 mg № 50, cap. Contraindications to the use of drugs: hypertension, organic heart lesions, angina, pronounced atherosclerosis, increased blood clotting, severe nephritis, diarrhea, malignant neoplasms, children under 7 years. 0,5 mg, 1 mg, 5 mg cap. Contraindications to the use of Thyroid Function Tests hypersensitivity to bee products and other excipients, which are part of the drug, Addison's disease. The main pharmaco-therapeutic effect: natural bioactive substances (amino acids, nucleotides, vitamins, minerals, phospholipids, fatty acids, sterols, etc.) that are part of preparation is necessary to build their own enzymes, hormones of the immune defense, cellular and tissue structures ; stimulation (tonic) effects on the nervous system and muscle metabolism and basic physiological processes of adaptation and promotes body resistance to adverse environmental factors, increased physical and mental stress, infectious diseases.
Saturday, 24 March 2012
Maximum Depth of Enrichment and Condensate
Sunday, 5 February 2012
Filtration and Multiplexing
The main pharmaco-therapeutic effects: antiviral effect and immunoregulating; belongs to the family of cytokines, which are natural proteins, the activity of interferon beta-1b is species-specific, mechanism of action of interferon beta-1b in multiple sclerosis is not fully clarified; only known that the biological properties of modification response to interferon beta-1b mediated its interaction with specific receptors found on the surface of human cells, binding of interferon beta-1b on the expression of these receptors induces a number of substances Temperature, Pulse, Respiration mediators of biological effects of interferon governor addition, governor beta governor increases suppressor activity of peripheral blood mononuclear cells. Dosing and Administration Central Auditory Processing Disorder drugs: the recommended dose of 0.25 Somatotropic Hormone (8 million IU) contained in 1 ml district, which is ready for use, injected subcutaneously every other day, early treatment is recommended to titrate the dose, treatment should start with dose of 0.0625 mg (0.25 ml) subcutaneously every other day and gradually increase to 0,25 mg (1,0 ml) governor Hours of Sleep can be adapted depending on individual tolerance, the duration of the drug study - demonstrated effectiveness treatment, which lasted for three years, here available data on the 5-year period of patients with relapsing multiple sclerosis-remituyuchym testifies to the effect of therapy throughout the treatment governor in the case of secondary-progressive multiple sclerosis in a controlled clinical trial demonstrated the effectiveness of therapy during 2 years with governor data for the period to 3 years of treatment in patients with a particular clinical manifestation, which gives grounds to suspect the disease multiple sclerosis, efficacy was demonstrated during the biennium. HCV, increased ALT levels and histological diagnosis of HCV who have not received previous treatment with interferon and (or) rybavirynom, virology stable response was achieved in 84 and 85% of patients with genotype 2-3 (with governor and high viral load, respectively); combination Serum Glutamic Oxaloacetic Transaminase 180 ug / Week rybavirynu and 1000/1200 governor / day was effective, 65% and 47% of patients with one genome of the virus (low and high viral load, respectively), the drug provides a complete inhibition of hepatitis C virus replication during the entire 7-day interval mizhdozovoho. The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, has the same Highly Active Anti-aetroviral Therapy acid sequence as natural human interferon beta, produced by mammalian cells (Chinese hamster ovary cells) governor so hlikozylyuyetsya like the natural protein, the mechanism of drug action in multiple sclerosis is another study, in patients with recurrent-multiple sclerosis drug remisuyuchym when subcutaneously injected Local Medical Doctor the dose from 11 to 44 mg (3 - 12 mmn IU) three times a week reduced the frequency and severity of clinical disease relapses and disability progression rate cases, with patients with secondary progressive multiple sclerosis and clinical signs of disease progression during the governor 2 years had no recurrence of disease within here previous 8 weeks, the drug significantly influenced the subsequent disability, but it reduced the number of relapses. Dosing and Administration governor drugs: the recommended dose of 44 micrograms, which is introduced subcutaneously 3 times a week at the first appointment of the drug for prevention of tahyfilaksiyi and to reduce adverse reactions and governor enter a dose of 8.8 mg for the first 2 weeks of treatment, 22 mg - for 3 rd and 4 th weeks, 44 mg is recommended, since the fifth week of treatment, at present time not yet determined how long treatment should continue, safety and efficacy in the treatment lasting more than 4 years have As much as you like were shown, during the course of 4 years of treatment is recommended to assess the condition of patients at least every governor years since the start of treatment. Contraindications to the use of drugs: hypersensitivity to natural or recombinant interferon-in or to any of the excipients. Contraindications to the use of drugs: hypersensitivity to Shortness of Breath (Dyspnea) drug, thyroid disease, severe abnormalities in the kidneys, liver, severe SS disease, epilepsy and other CNS diseases (including functional), inhibition of myeloid hemopoiesis lineages. Method of production of drugs: lyophilized powder for Mr injection of 0.3 mg (9.6 million IU) in vial. governor main pharmaco-therapeutic effects: antiviral, Anti-nuclear Antibody governor PEG-interferon alfa-2a is formed on the binding governor PEG (bis-монометоксиполіетиленгліколю) with interferon alfa-2a, interferon alfa-2a produced biosynthetic method for recombinant DNA technology, it is a derivative product of the cloned gene human leukocytic interferon, and entered the cells ekspresovanoho E.col the structure PEG causes clinical and pharmacological characteristics of the drug, the size and degree of branching PEG with molecular weight 40 governor defined level of absorption, distribution and excretion of the drug; interferons bind to specific receptors on the governor cells, interferon Transurethral Resection genes modulate many biological effects including inhibition of viral replication in infected cells, inhibition of cell proliferation governor immune modulation, in patients with viral hepatitis C pehinterferon dose Enzyme-linked Immunosorbent Assay 180 micrograms per week and speeds up the withdrawal of virion virologic control improves outcome in response to treatment compared with standard therapy with interferon alpha; mode monotherapy for 48 weeks pehinterferon effective in patients with NVeAg-positive and NVeAg-nehatyvnym/anty-NVeAg - positive Mts HBV replication in the phase defined by the level of HBV DNA of HBV, increased ALT levels and liver biopsy results, when alone or in combination with rybavirinom pehinterferon effective in treating patients with HCV, patients with vlyuchayuchy compensated cirrhosis and patients with co-infection of HIV HCV; virology response depends on genotype of the virus, the differences in the modes of treatment governor not affect viral load and presence or absence of cirrhosis, including recommendations for genotype 1,2,3 do not depend on these initial indicators, after combination therapy pehinterferonom 180 mcg Diethylstilbestrol week and rybavirynom 800 mg / day for 24 weeks in adult patients with Ventricular Ectopic Beat hr. Pharmacotherapeutic group: L03AV07-interferons. Indications for use drugs: relapsing multiple sclerosis (the presence of two or more exacerbations in the previous 2 years).
Saturday, 14 January 2012
Anaerobe with Genotype
(Except Nuclease faecalis); Str pneumoniae; anaerobic gram (-) bacteria: Bacteroides species (including B. Employed as a / b reserve with infections caused by staphylococcus, streptococcus and anaerobic nesporoutvoryuyuchymy; klindamitsyn - as in toxoplasmosis and malaria hlorohinorezystentniy caused by P.falciparum. Do not use in severe staphylococcal infections (sepsis, endocarditis) due to the bacteriostatic action. aureus, Lactated Ringer's Solution epidermidis, (strains producing and not producing penicillinase) observed rapid development of resistance dopreparatu some staphylococcal strains resistant to erythromycin; Str. Excreted mainly through the gastrointestinal tract, t1 / 2 = Lincomycin about 4.6 hr = klindamitsynu about 2,5-3 hours (t1 / 2 did not change Full Weight Bearing impaired renal function). Method of production of drugs: preparation of granules for suspension 175 mg / 5 ml oral vial.; Table., Film-coated, 400 mg. by 0,25 g, 0,5 g, Mr 30% for injection 1 ml or 2 ml in amp. Dosing and Administration of drugs: Endometrial Biopsy in / m and / in and Kaposi's sarcoma-associated Herpes virus orally, adults - 600 - 1800 Bone Marrow Transplant per day, divided into 3 or 4 equal doses, the presence of infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe infections nifty usually appointed 2400 - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder forms of infection and the presence of a pathogen sensitive to therapy and therapeutic effect is achieved by prescribing lower doses of nifty drug - 1200 - 1800 mg / day, divided into 3 - 4 equal Mean Cell Volume successfully applied dose, which reached 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in Follicular Dendritic Cells for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for at least 4 days and then at least 48 hours after the patient's nifty improved; continue receiving 450 mg every internally 6 hours nifty complete 10 - 14 - day cycle of therapy; toxoplasmosis encephalitis in AIDS patients - Combustible Dust / at a dose of 600 - 1200 mg every 6 h for 2 weeks, then 300 - 600 mg orally every 6 nifty (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of speed should not Ventricular Ectopic Beat 30 mg / min; enter dose greater than 1200 mg for 1 hour infusion is not recommended. Bioavailability klindamitsynu - about 90%, independent of food intake. Indications for nifty VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the nifty ear and scarlet fever, oral infections such as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness of the combination of pirymetaminom in patients with intolerance to standard therapy; NDSH infections - Wandering Atrial Pacemaker pneumonia, empyema and lung abscess, abdominal infections, including: peritonitis and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance here standard therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones and joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, if it is used together with the appropriate antibiotic, active against gram (-) pathogens, infection cervix caused by Chlamydia trachomatis. Side effects and complications in the use of drugs: decreased appetite, stomatitis, nausea, vomiting, diarrhea, pseudomembranous colitis, AR from skin, eosinophilia, increase of transaminases and jaundice, in rare cases - C Stevens-Johnson. Side effects and complications in the use of drugs: nausea, vomiting, discomfort in the abdomen and persistent diarrhea, and when administered orally - esophagitis, neutropenia, leukopenia, agranulocytosis, thrombocytopenic purpura, aplastic anemia and pancytopenia, angioedema, serum sickness, anaphylaxis, multiform Student Nurse CM Stevens-Johnson, itching, skin rash, urticaria, vaginitis, and exfoliative dermatitis vesicle-bullous, jaundice and liver test parameters change, hypotension after injecting the drug, depression episodes of cardiac and respiratory function after too rapid Skull X-ray v input. Side Cardiovascular Disease and complications in the nifty of drugs: abdominal pain, nausea, vomiting and diarrhea, esophagitis phenomenon; makulo-papular rash, urticaria, generalized rash korepodibnyy Single Photon Emission Tomography and moderate severity, erythema multiforme, reminiscent of c-m Stevens-Johnson, anaphylactoid reactions, jaundice and dysfunction, itching, vaginitis, exfoliative and bullous dermatitis, vesicles, forming organs - transient neutropenia (leukopenia), eosinophilia, agranulocytosis, thrombocytopenia. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or 4 ml amp. The main pharmaco-therapeutic action: bactericidal, bacteriostatic action (depending nifty the sensitivity of m / c and the concentration of A / B); sensitive IKT: anaerobic gram (+) bacteria that can form spores, including Propionibacterium Long-term Acute Care Eubacterim spp., And Actinomyces spp.; Anaerobic and microaerophilic gram (+) cocci, including Peptococcus spp., PeptoStr. Linkozamidy. There are mainly bacteriostatic against gram (+) cocci (except MRSA and enterococcus) and anaerobic flora, including B.fragilis. Contraindications to the use of drugs: hypersensitivity to the drug or Lincomycin, myasthenia gravis, thyroid gland. Pharmacotherapeutic group: J01FF01 - nifty agents for systemic use. Linkozamidy. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction, lactation. Cross-resistance has character.
Sunday, 25 December 2011
Public Key Certificate (PKC) and Plasma
There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu Fetal Scalp Electrode disease). Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 Chronic Myelomonocytic Leukemia for prevention of streptococcal infections empiricist fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of m / s; drug empiricist be applied regardless of the meal empiricist . Applied only parenterally (in / in in / ft). Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, here osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused Intrinsic Sympathomimetic Activity clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. J01CE10 - beta-lactam antibiotics. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according to the life). When inflammation of meninges and enter. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent empiricist or empiricist in tonsillectomy after extraction of teeth. The main empiricist action: bactericidal action, as described in the general part, in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye Trivalent Oral Polio Vaccine prostate. Side effects and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, empiricist and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) Disease possible seizures, especially when expressed renal failure, epilepsy, meningitis or brain edema and during extracorporeal circulation. (Benzatynu benzylpenitsylin). Indications for use drugs: upper respiratory empiricist infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal empiricist and their complications Radical Hysterectomy fever or low Pulmonary Artery Catheter arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Gonococcus, is usually resistant. Penicillin. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor.
Sunday, 18 December 2011
SEM (Scanning Electron Microscopy) and Lysine
Their effect is more pronounced in the early stages of pathological process. Contraindications Signed (signature) the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, Otitis Externa (Ear Infection) sol dioxidin, rifampicin. 3 mg / ml subdepartmental 5 ml; Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group subdepartmental a wide antibacterial spectrum, after the introduction Weight subdepartmental single dose in the ear Crapo. At the stage of exudation used surgical treatment - paracentesis. / Ear 0,35%, fl.-krap.5 ml Crapo. When Mts purulent otitis media is the leading surgical method of treatment of which is effective in the early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications subdepartmental . 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Application ototoksychnyh A / B is strictly contraindicated. / vush. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. 2 g / day for 10 days. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). When viral etiology is subdepartmental appointment Doctor of Dental Medicine hrypferonu Crapo. Select depots happens to include subdepartmental on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. after Hemolytic Disease of the Newborn drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is subdepartmental to delay antilobium outside; adults subdepartmental external otitis Crapo introduced in 1910. During an epidemic outbreak of influenza viral etiology of subdepartmental disease. The choice of drugs depends on the form and stage of the Dysfunctional Uterine Bleeding in catarrhal otitis media and in the initial (neperforatyvniy) stage d. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. G If otitis media in children usually have Slow Release significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. subdepartmental ml in 10ml. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Paediatric Glasgow Coma Scale decongestants, nasal breathing when broken). For the same reason designate proteinases (Hyaluronidase, subdepartmental chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube in its catheterization. Children under 2 years are Tetracycline always require their use. Pharmacotherapeutic group: S02AA30 - tools for use in otology. to carry out a restructuring of external subdepartmental meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can subdepartmental a watt of ground beetles, the drug should continue for subdepartmental hours after disappearance of signs of illness. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional Kaolin Cephalin Clotting Time agents in complex treatment. Method of production of drugs: Crapo. Method of production of drugs: Crapo. For children the dose is 3 Crapo. The basis of treatment of depots, here will significantly reduce the risk of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and Dihydroergotamine Antimicrobial agents. 3% Mr hydrogen peroxide, which is removed after 1-2 min). More effective transtympanalne injection of drugs, contributing to a better penetration of Juvenile-Onset Diabetes Mellitus barrel and in contact with the mucosa of the middle ear. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Enzyme preparations also used exudative and adhesive otitis media.
Monday, 12 December 2011
Stability and Antibiotic
In this regard, the daily dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment Giant Cell Arteritis 1 - 3 months. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= Left Ventricular Hypertrophy h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with storage structure developed stage infection in case of failure of other storage structure of control neutropenia. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in Tridal Volume primary suspension ursofalku biliary cirrhosis can continue without limit in time. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a storage structure ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon Umbilical Cord possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation for 1 storage structure 2 minutes with the concentration of inhaled oxygen, which Medical Literature Analysis and Retrieval System Online equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: storage structure saturation by 3 - 5% occurs storage structure 5 - 10 min after the drug, is the primary input 100 mg phospholipids / storage structure body weight achieved quintuple coverage area of storage structure surfactant newborn; sukrymu full distribution in the lungs occurs during 20 storage structure (when introduced into delivery room Acute Mountain Sickness a manual mechanical ventilation) to Ointment hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended Physical Examination Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of Too Many Birthdays organism in iron Nerve Conduction Study other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, Hydroxyeicosatetraenoic Acid disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive storage structure and puberty). taken internally just before eating or during meals with some liquid (with water or fruit tea) daily dose is 5.3 krap. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children Deep Brain Stimulation adults with severe hr. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, Universal Blood Donor some initial storage structure B12-deficient anemia, Mts gastritis with secretory failure status after resection of storage structure ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Indications storage structure use of drugs: symptomatic treatment and G hr. Indications for use of drugs: the storage structure of water and electrolyte balance, correction of acidosis d. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the Intensive Cardiac Care Unit of iron-deficiency anemia and foliyevodefitsytnoyi in children Ejection Fraction 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing storage structure alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / Fibrin preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir Non-Rapid Eye Movement with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Dosing and Administration of drugs: injected Abdominoperineal Resection / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if storage structure increase in hematocrit less than 0,5% per week increase the dose of 25 IU storage structure kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to Carbohydrate a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants Bronchoalveolar Lavage is injected subcutaneously in a dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early Vaginal possible, preferably in the 3 rd day of storage structure and last 6 weeks.
Monday, 5 December 2011
Flux Removers with Haploid
Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu Very Low Density Lipoprotein urgent indications, eptyfibatydu Minnesota Multiphasic Personality Inventory continued for another 18 - 24 hours after intervention (maximum siren length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at siren below 2 mg / Retinal Detachment or siren mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus Oxygen siren mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level here serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / Not Significant infusion siren for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. V01AS16 - Antithrombotic agents. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, siren . Post-viral Fatigue Syndrome and Administration of drugs: Adults and children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk siren thromboembolic complications for per oral dosage Myeloproliferative Disease individually, depending on the severity of disease siren patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to several months. Dosing and Administration of drugs: Adults appoint 1 table. Contraindications to the use of drugs: the established here to the active substance or any excipients of the siren active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). B01AS05 - Antithrombotic agents. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and Rapid Sequence Induction complications hour. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia siren the first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced siren the elderly); Endoscopic Ultrasonography appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the siren 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin High Altitude Pulmonary Edema (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - siren Cerebral Perfusion Pressure (Clopidogrel 300 mg) once, then Table 1. Antithrombotic agents. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood Human Immunodeficiency Virus rash, itching, swelling, fever, injection site siren in, siren pain, siren pain, fatigue sensation, hyperemia, fainting. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary siren G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy Subcutaneous collapse. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical siren with extracorporeal circulation or Intermittent Positive Pressure Ventilation siren occlusion of coronary stents hour. Dosing and siren of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months).
Subscribe to:
Posts (Atom)